Complete response to pembrolizumab and radiation in a patient with HIV-negative, EBV-positive plasmablastic lymphoma

被引：7
作者：
Castillo, Jorge J. [1 ,2 ]
Lamacchia, John [2 ,3 ]
Silver, Joel [4 ]
Flynn, Catherine A. [1 ]
Sarosiek, Shayna [1 ,2 ]
机构：
[1] Dana Farber Canc Inst, Div Hematol Malignancies, 450 Brookline Ave,Mayer 221, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[4] Reg Canc Care Associates, Hartford, CT USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 10期
关键词：
D O I：
10.1002/ajh.26291
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E390 / E392
页数：3
相关论文
共 8 条
[1]   Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma [J].
Castillo, Jorge J. ;
Guerrero-Garcia, Thomas ;
Baldini, Francesco ;
Tchernonog, Emmanuelle ;
Cartron, Guillaume ;
Ninkovic, Slavisa ;
Cwynarski, Kate ;
Dierickx, Daan ;
Tousseyn, Thomas ;
Lansigan, Frederick ;
Linnik, Yevgeny ;
Mogollon, Renzo ;
Navarro, Jose-Tomas ;
Olszewski, Adam J. ;
Reagan, John L. ;
Fedele, Pasquale ;
Gilbertson, Michael ;
Grigoriadis, George ;
Bibas, Michele .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) :679-682
[2]   The biology and treatment of plasmablastic lymphoma [J].
Castillo, Jorge J. ;
Bibas, Michele ;
Miranda, Roberto N. .
BLOOD, 2015, 125 (15) :2323-2330
[3]   Therapeutic Potential of Checkpoint Inhibitors in Refractory Plasmablastic Lymphoma [J].
Damlaj, Moussab ;
Alzayed, Mohammed ;
Alahmari, Bader ;
Alhejazi, Ayman ;
Alaskar, Ahmed ;
Alzahrani, Mohsen .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) :E559-E563
[4]   Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors [J].
Dolladille, Charles ;
Ederhy, Stephane ;
Allouche, Stephane ;
Dupas, Querntin ;
Gervais, Radj ;
Madelaine, Jeannick ;
Sassier, Marion ;
Plane, Anne-Flore ;
Comoz, Francois ;
Cohen, Ariel Aron ;
Thuny, Franck Roland ;
Cautela, Jennifer ;
Alexandre, Joachim .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
[5]   Bortezomib plus CHOP for the treatment of HIV-associated plasmablastic lymphoma: clinical experience in three patients [J].
Fernandez-Alvarez, Ruben ;
Gonzalez-Rodriguez, Ana P. ;
Rubio-Castro, Arturo ;
Esther Gonzalez, M. ;
Ramirez Payer, Angel ;
Alonso-Garcia, Ana ;
Rodriguez-Villar, Diana ;
Dominguez-Iglesias, Francisco ;
Sancho, Juan M. .
LEUKEMIA & LYMPHOMA, 2016, 57 (02) :463-466
[6]   Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination [J].
Gong, Jun ;
Le, Thang Q. ;
Massarelli, Erminia ;
Hendifar, Andrew E. ;
Tuli, Richard .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
[7]  
Rosado FG, 2021, ANN CLIN LAB SCI, V51, P174
[8]  
Stein H, 2008, WHO CLASSIFICATION T, P256
1